ResMed (RMD)
(Delayed Data from NYSE)
$210.91 USD
-0.65 (-0.31%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $210.93 +0.02 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Brokerage Reports
ResMed Inc. [RMD]
Reports for Purchase
Showing records 421 - 440 ( 528 total )
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q2 FY2017 ahead of consensus and nice rebound from Q1, maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Q4 CY2016 Feltl CPAP Project 2005-2016: 19,000+ patient historical analysis
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q1 FY2017 missed consensus, Americas mask share slips, maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Q3 CY2016 CPAP Project 2005-2016: 19,000+ patient historical analysis
Provider: Feltl & Company
Analyst: HAYNOR B
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Q4 FY2016 revenue ahead of expectations, target to $65, maintain HOLD
Provider: Feltl & Company
Analyst: HAYNOR B